These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29110852)

  • 21. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography: Comparison with Solitary Invasive Adenocarcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2016 May; 11(5):729-736. PubMed ID: 26802286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung cancer with scattered consolidation: detection of new independent radiological category of peripheral lung cancer on thin-section computed tomography.
    Matsunaga T; Suzuki K; Hattori A; Fukui M; Kitamura Y; Miyasaka Y; Takamochi K; Oh S
    Interact Cardiovasc Thorac Surg; 2013 Apr; 16(4):445-9. PubMed ID: 23248167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing Part-Solid and Pure-Solid Tumors in the TNM Classification of Lung Cancer (Eighth Edition).
    Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T
    Thorac Cardiovasc Surg; 2019 Jun; 67(4):306-314. PubMed ID: 29843187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
    Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
    Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules.
    Iwano S; Umakoshi H; Kamiya S; Yokoi K; Kawaguchi K; Fukui T; Naganawa S
    Cancer Imaging; 2019 Jun; 19(1):33. PubMed ID: 31174613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Thorac Cardiovasc Surg; 2017 Mar; 65(2):142-149. PubMed ID: 26902328
    [No Abstract]   [Full Text] [Related]  

  • 28. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is limited resection appropriate for radiologically "solid" tumors in small lung cancers?
    Hattori A; Suzuki K; Matsunaga T; Fukui M; Kitamura Y; Miyasaka Y; Tsushima Y; Takamochi K; Oh S
    Ann Thorac Surg; 2012 Jul; 94(1):212-5. PubMed ID: 22560966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer.
    Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visceral pleural invasion is not a significant prognostic factor in patients with a part-solid lung cancer.
    Hattori A; Suzuki K; Matsunaga T; Takamochi K; Oh S
    Ann Thorac Surg; 2014 Aug; 98(2):433-8. PubMed ID: 24961845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions.
    Fu F; Zhang Y; Wen Z; Zheng D; Gao Z; Han H; Deng L; Wang S; Liu Q; Li Y; Shen L; Shen X; Zhao Y; Zhao Z; Ye T; Xiang J; Zhang Y; Sun Y; Hu H; Chen H
    J Thorac Oncol; 2019 Dec; 14(12):2133-2142. PubMed ID: 31437531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extent of mediastinal nodal dissection in stage I non-small cell lung cancer with a radiological pure-solid appearance.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Surg Oncol; 2021 Jul; 47(7):1797-1804. PubMed ID: 33745792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
    Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
    Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the IASLC/ATS/ERS classification in pN0 pulmonary adenocarcinomas: a study with radiological-pathological comparisons and survival analyses.
    Ambrosini-Spaltro A; Ruiu A; Seebacher C; Vattemi E; Gentile L; Feil B; Zaraca F; Carella R
    Pathol Res Pract; 2014 Jan; 210(1):40-6. PubMed ID: 24211161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncological outcomes of sublobar resection for clinical-stage IA high-risk non-small cell lung cancer patients with a radiologically solid appearance on computed tomography.
    Hattori A; Takamochi K; Matsunaga T; Oh S; Suzuki K
    Gen Thorac Cardiovasc Surg; 2016 Jan; 64(1):18-24. PubMed ID: 26486132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Features of Ground Glass Opacity-Dominant Lung Cancer Exceeding 3.0 cm in the Whole Tumor Size.
    Suzuki S; Sakurai H; Yotsukura M; Masai K; Asakura K; Nakagawa K; Motoi N; Watanabe SI
    Ann Thorac Surg; 2018 May; 105(5):1499-1506. PubMed ID: 29427615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
    Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
    Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance.
    Hattori A; Matsunaga T; Fukui M; Tomita H; Takamochi K; Suzuki K
    J Thorac Cardiovasc Surg; 2024 Sep; 168(3):685-696.e2. PubMed ID: 37995863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.
    Sun K; You A; Wang B; Song N; Wan Z; Wu F; Zhao W; Zhou F; Li W
    Eur Radiol; 2021 Oct; 31(10):7353-7362. PubMed ID: 33860370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.